A Rational Combination of Cyclocarya paliurus Triterpene Acid Complex (TAC) and Se-Methylselenocysteine (MSC) Improves Glucose and Lipid Metabolism via the PI3K/Akt/GSK3β Pathway

Xichen Bai,Hong Zhou,Dan Luo,Dan Chen,Jianyuan Fan,Xiaoting Shao,Jun Zhou,Wei Liu

DOI: https://doi.org/10.3390/molecules28145499

IF: 4.6

2023-07-19

Molecules

Abstract:Cyclocarya paliurus (CP) contains triterpene acids that can improve glucose and lipid metabolism disorders. However, controlling the composition and content of these active ingredients in CP extracts is challenging. The main active components in CP triterpene acids, including ursolic acid (UA), oleanolic acid (OA), and betulinic acid (BA), exhibit antihyperglycemic and antihypertensive effects. The response surface methodology was utilized to design and optimize the ratio of UA, OA, and BA based on the inhibition rate of pancrelipase and α-amylase. The proportional mixture of UA, OA, and BA resulted in the formation of a complex known as Cyclocarya paliurus triterpenoid acid (TAC). Se-methylselenocysteine (MSC), a compound with various physiological functions such as antioxidant properties and tumor inhibition, has been used in combination with TAC to form the TAC/MSC complex. Our data demonstrate that TAC/MSC improved palmitic acid (PA)-induced insulin resistance in HepG2 cells through activating the phosphoinositide 3-kinase (PI3K) /protein kinase B (AKT)/glycogen synthase kinase 3 beta (GSK3β) pathway. Moreover, TAC/MSC effectively improved hyperglycemia, glucose intolerance, insulin resistance, and lipid metabolism disorder in mice with type 2 diabetes mellitus (T2DM), attenuated hepatic steatosis, and reduced oxidative stress to alleviate T2DM characteristics.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper primarily explores the effects of the rational combination of triterpenic acid compounds (TAC) from Cyclocarya paliurus (sweet tea tree) and Se-Methylselenocysteine (MSC) on glucose and lipid metabolism, and investigates the improvement of metabolism through the PI3K/Akt/GSK3 β signaling pathway.

### Research Background:
- Cyclocarya paliurus (CP) contains triterpenic acids that can improve glucose and lipid metabolism disorders.
- Controlling the composition and content of these active ingredients in CP extracts is challenging.
- The main active ingredients in CP include Ursolic Acid (UA), Oleanolic Acid (OA), and Betulinic Acid (BA), which have anti-hyperglycemic and antihypertensive effects.
- Se-Methylselenocysteine (MSC) is a compound with physiological functions such as antioxidant and antitumor activities.

### Research Objectives:
- Determine the optimal ratio of UA, OA, and BA to form the Cyclocarya paliurus triterpenic acid compound (TAC).
- Combine TAC with MSC to form the TAC/MSC compound and explore its effects on glucose and lipid metabolism.
- Verify whether the TAC/MSC compound can improve insulin resistance by activating the PI3K/Akt/GSK3 β signaling pathway.

### Research Methods:
- Use response surface methodology to design experiments to optimize the ratio of UA, OA, and BA.
- Test the effects of the TAC/MSC compound on glucose consumption, glycogen synthesis, and lipid accumulation in HepG2 cells.
- Detect the activation of the PI3K/Akt/GSK3 β signaling pathway through Western blot.
- Evaluate the effects of the TAC/MSC compound on body weight, food intake, and fasting blood glucose levels in a type 2 diabetes mouse model.

### Research Results:
- The optimal ratio obtained through optimization is: UA 348 µg/L, BA 354 µg/L, OA 398 µg/L, achieving an α-amylase inhibition rate of 63.9% and a pancreatic lipase inhibition rate of 67.2%.
- The TAC/MSC compound significantly increased glucose consumption, enhanced glycogen synthesis, and reduced lipid accumulation in HepG2 cells.
- The TAC/MSC compound improved insulin resistance by activating the PI3K/Akt/GSK3 β signaling pathway.
- In the type 2 diabetes mouse model, the TAC/MSC compound effectively improved hyperglycemia, poor glucose tolerance, insulin resistance, and lipid metabolism disorders, alleviated hepatic steatosis, and reduced oxidative stress.

In summary, this study aims to develop a new health food supplement—TAC/MSC compound, to alleviate the symptoms of type 2 diabetes by regulating glucose and lipid metabolism.